# DNA Analysis in Predicting Response to Antibody Therapy in Patients With Follicular Lymphoma Treated on Clinical Trials CALGB-50402 or CALGB-50701

> **NCT01057459** · — · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 78 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01057459
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2014-06-23
- **Final completion:** 2014-06-23
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2017-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01057459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01057459, "DNA Analysis in Predicting Response to Antibody Therapy in Patients With Follicular Lymphoma Treated on Clinical Trials CALGB-50402 or CALGB-50701". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01057459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*